Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;67(4):428-431.
doi: 10.4103/indianjpsychiatry.indianjpsychiatry_1084_24. Epub 2025 Apr 15.

Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study

Avinash Jhajharia  1 , Priyanka Saha  1 , Piyali Mandal  1 , Atul Ambekar  1
Affiliations

Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study

Avinash Jhajharia et al. Indian J Psychiatry. 2025 Apr.

Abstract

Background: Indian guidelines mention the use of buprenorphine in opioid withdrawal in both outpatient and inpatient setting.

Aim: This is the first study aiming at assessing the feasibility aspects of outpatient-based buprenorphine-assisted opioid withdrawal treatment for opioid dependence.

Methods: In this prospective observational study, 30 men with opioid dependence, planned for outpatient-based withdrawal management, were recruited by purposive sampling and were assessed at baseline, 2, 4, and 12 weeks using validated tools. Abstinence was validated by a urine toxicology screen.

Results: The median age of the sample was 24 (21.75-28.0) years. About 67% retained in treatment with a treatment perception score of 4.1 (4.0-4.4) and a significant reduction of craving and withdrawal scores. More than 80% were abstinent at 12 weeks.

Conclusion: The study findings suggest that outpatient-based buprenorphine-assisted acute opioid withdrawal management is a feasible and acceptable treatment. Considering the relatively few inpatient addiction treatment settings, the findings are promising.

Keywords: Buprenorphine; opioid withdrawal; outpatient.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Ambekar A, Agrawal A, Rao R, Mishra, AK Khandelwal SK, Chadda RK. Magnitude of Substance Use in India. 2019. Available from: http://socialjustice.nic.in/writereaddata/UploadFile/Magnitude_Substance... .
    1. Ambekar A, Goyal S. New Delhi: Indian Psychiatric Society; 2015. Synopsis of the Clinical Practice Guidelines on Management of Opioid Use Disorders.
    1. Ziaaddini H, Nasirian M, Nakhaee N. Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents. Addict Health. 2012;4:79–80. - PMC - PubMed
    1. Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020;395:1938–48. - PMC - PubMed
    1. Jain N, Chavan BS, Sidana A, Das S. Efficacy of buprenorphine and clonidine in opioid detoxification: A hospital- based study. Indian J Psychiatry. 2018;60:292–9. - PMC - PubMed

LinkOut - more resources